West Pharma forecasts 2026 profit above estimates on strong demand for drug components

Core Insights - West Pharmaceutical is forecasting annual profit above Wall Street estimates following a strong fourth-quarter performance driven by high demand for its proprietary products, including syringes [1] Group 1 - The company reported better-than-expected fourth-quarter results, indicating robust demand for its proprietary products [1] - The forecast for annual profit suggests a positive outlook, exceeding market expectations [1]